Relationship between serum indirect bilirubin levels and skeletal muscle mass in older male and female patients with type 2 diabetes.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
02
2022
accepted:
18
10
2022
entrez:
2
11
2022
pubmed:
3
11
2022
medline:
5
11
2022
Statut:
epublish
Résumé
We previously showed that low serum bilirubin levels are associated with disability in quality of daily living in older patients with diabetes. However, the underlying mechanism is not fully understood. The aim of this study is to assess the relationship between serum bilirubin levels and skeletal muscle mass in older patients with type2 diabetes. A total of 272 older patients with type2 diabetes (152 male and 120 female) aged 60 years and over were continuously recruited from April 2020 to July 2020. Body composition was evaluated by bioelectrical impedance analysis. The skeletal muscle mass index (SMI) was calculated as appendicular muscle mass divided by height squared (m2). The SMI was markedly lower in old-old patients (aged 75 years and over) than in young-old patients (aged 60-74 years) in both male and female (7.1 ± 0.8 kg/m2 vs 7.6 ± 0.9 kg/m2, P<0.001; 5.5 ± 0.9 kg/m2 vs 6.3 ± 0.8 kg/m2, P<0.001, respectively). Multivariate regression analysis showed that the SMI was associated with body mass index (BMI) (p<0.001) and age (p = 0.048) in male young-old patients, while it was associated with BMI (p<0.001), age (p = 0.008), and serum indirect bilirubin levels (p = 0.038) in male old-old patients. In female, the SMI was associated with BMI (p<0.001) and age (p = 0.042) in young-old patients and associated with BMI alone (p<0.001) in old-old patients. Serum indirect bilirubin levels may be associated with the decreased skeletal muscle mass in male older patients (aged 75 years and over) with type 2 diabetes.
Identifiants
pubmed: 36322557
doi: 10.1371/journal.pone.0276976
pii: PONE-D-22-03319
pmc: PMC9629548
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0276976Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Diabetes Care. 2009 Nov;32(11):1993-7
pubmed: 19549734
Acta Diabetol. 2013 Apr;50(2):251-60
pubmed: 22732903
J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):324-33
pubmed: 15860469
Circulation. 2006 Oct 3;114(14):1476-81
pubmed: 17000907
Sci Rep. 2019 May 8;9(1):7069
pubmed: 31068612
J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):B443-8
pubmed: 11584029
Sci Rep. 2016 Dec 13;6:38937
pubmed: 27958337
Diabetologia. 2011 Aug;54(8):2183-91
pubmed: 21614569
Kidney Int. 2010 Nov;78(9):905-19
pubmed: 20686447
Free Radic Biol Med. 2001 Dec 1;31(11):1405-16
pubmed: 11728812
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Diabet Med. 2010 May;27(5):603-6
pubmed: 20536960
Sci Rep. 2021 Apr 13;11(1):8026
pubmed: 33850200
Endocr Rev. 2005 Oct;26(6):833-76
pubmed: 15901667
J Appl Physiol (1985). 2016 Nov 1;121(5):1047-1052
pubmed: 27197856
JAMA. 2007 Sep 26;298(12):1398-400
pubmed: 17895455
Science. 2000 Sep 29;289(5488):2363-6
pubmed: 11009425
Geriatr Gerontol Int. 2015 Aug;15(8):1013-22
pubmed: 25345548
Maturitas. 2011 Apr;68(4):331-6
pubmed: 21353405
PLoS One. 2021 Feb 11;16(2):e0243407
pubmed: 33571217
Age (Dordr). 2016 Feb;38(1):1
pubmed: 26695510
Diabetes Metab Syndr Obes. 2019 Jul 08;12:1057-1072
pubmed: 31372016
Int J Mol Sci. 2010 Apr 12;11(4):1509-26
pubmed: 20480032
J Signal Transduct. 2012;2012:982794
pubmed: 22175016
Diabetes Care. 2010 Jul;33(7):1497-9
pubmed: 20413515
Gerontology. 2015;61(5):407-15
pubmed: 25924722
J Diabetes Investig. 2021 Nov;12(11):2028-2035
pubmed: 33949141
PLoS One. 2013;8(3):e60119
pubmed: 23533671
J Diabetes Res. 2020 Oct 07;2020:3950404
pubmed: 33083494
Pract Lab Med. 2017 May 17;8:77-85
pubmed: 28856232
Science. 1987 Feb 27;235(4792):1043-6
pubmed: 3029864
Maturitas. 2017 May;99:66-72
pubmed: 28364871